Stocktoria
PETMED EXPRESS INC PETS
Nasdaq · XNAS · stock · Retail-Drug Stores and Proprietary Stores · website · IPO 2000-04-06
PETMED EXPRESS INC financials (annual, from 10-K)
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $179.0M | $227.0M | $281.1M | $256.6M | $272.3M |
| Gross profit | $50.2M | $69.1M | $84.8M | $76.5M | $76.9M |
| Operating income | -$58.7M | -$1.5M | -$8.2M | $6.1M | $24.3M |
| Income tax | -$73,000 | $5.7M | $1.2M | $2.3M | $5.5M |
| Net income | -$57.3M | -$6.3M | -$7.5M | $5.1M | $18.7M |
| EPS (diluted) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.92 |
| Operating cash flow | -$28.4M | $4.7M | $4.3M | $27.8M | $18.5M |
| Free cash flow | -$33.0M | -$395,000 | -$194,000 | $22.5M | $16.7M |
| Cash & equivalents | $21.4M | $54.7M | $55.3M | $104.1M | $111.1M |
| Inventory | $13.6M | $16.2M | $28.6M | — | — |
| Total assets | $81.2M | $148.7M | $169.9M | $167.5M | $176.3M |
| Total liabilities | $52.3M | $63.6M | $73.2M | $57.5M | $34.1M |
| Shareholders' equity | $28.9M | $85.1M | $96.7M | $110.0M | $123.5M |
Source: SEC EDGAR filings · CIK 0001040130 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.